SCHEMBL30108036

SCHEMBL30108036

COc1ccc2c(c1)nnn2-c1cc(N2CCC2)nc(Cl)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.46
ALDH1A1 P00352 6/20 0.42
KDM4E B2RXH2 5/20 0.42
HPGD P15428 4/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
EZH2 Q15910 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
RAB9A P51151 1/20 0.37
CASP1 P29466 3/20 0.37
NPSR1 Q6W5P4 2/20 0.37
CASP4 P49662 2/20 0.37
CASP5 P51878 2/20 0.37
MAPT P10636 2/20 0.37
GFER P55789 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30108038 0.88 PIM1 (0.46) PIM1ALDH1A1KDM4EHPGDCYP1A2
SCHEMBL30107975 0.84 L3MBTL1 (0.40) PIM1ALDH1A1KDM4ESMN1; SMN2NPC1
SCHEMBL30107968 0.76 IDH1 (0.35) PIM1ALDH1A1SMN1; SMN2NPC1GAA
SCHEMBL30107983 0.76 PDE10A (0.41) PIK3CAPDE2APDE10A
SCHEMBL30107973 0.75 KDM4E (0.46) ALDH1A1KDM4EHPGDSMN1; SMN2NPC1
SCHEMBL30107965 0.73 MET (0.40) ALDH1A1KDM4ESMN1; SMN2RAB9ANPSR1
SCHEMBL30107966 0.73 TSHR (0.40) PIM1ALDH1A1KDM4ECYP1A2CYP2C19
SCHEMBL4590708 0.71 L3MBTL1 (0.48) KDM4EHPGDCYP1A2CYP2C19NPC1
SCHEMBL13728941 0.69 KDM4E (0.62) ALDH1A1KDM4EHPGDCYP1A2CYP2C19
SCHEMBL30107974 0.67 MAPT (0.40) PIM1ALDH1A1KDM4ESMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022203399-A1 ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF 주식회사 스탠다임 2022-09-29 WO disclosed